EyePoint Pharmaceuticals, Inc. (EYPT): Price and Financial Metrics
EYPT Price/Volume Stats
| Current price | $8.25 | 52-week high | $13.98 |
| Prev. close | $8.20 | 52-week low | $3.91 |
| Day low | $7.98 | Volume | 466,700 |
| Day high | $8.31 | Avg. volume | 839,826 |
| 50-day MA | $6.10 | Dividend yield | N/A |
| 200-day MA | $7.77 | Market Cap | 567.69M |
EYPT Stock Price Chart Interactive Chart >
EyePoint Pharmaceuticals, Inc. (EYPT) Company Bio
EyePoint Pharmaceuticals (formerly pSivida Corp.) develops sustained-release drug-delivery products for treating eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior uveitis. The company was founded in 1987 and is based in Watertown, Massachusetts.
EYPT Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
EYPT Price Returns
| 1-mo | 35.47% |
| 3-mo | 15.71% |
| 6-mo | -5.28% |
| 1-year | -11.00% |
| 3-year | -6.88% |
| 5-year | 0.43% |
| YTD | 10.74% |
| 2024 | -67.76% |
| 2023 | 560.29% |
| 2022 | -71.41% |
| 2021 | 86.02% |
| 2020 | -57.55% |